The relationship of sterol regulatory element-binding protein cleavage-activation protein and apolipoprotein E gene polymorphisms with metabolic changes during weight reduction

Metabolism: Clinical and Experimental

Volumn 56, Issue 7, 2007, Pages 876-880

  Nieminen, Tuomo ^a   Matinheikki, Jussi ^b   Nenonen, Arja ^b,c,d   Kukkonen Harjula, Katriina ^c   Lindi, Virpi ^e   Hämelahti, Päivi ^b   Laaksonen, Reijo ^f   Fan, Yue Mei ^b   Kähönen, Mika ^b   Fogelholm, Mikael ^c   Lehtimäki, Terho ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^d RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE ACTIVATION PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; APOLIPOPROTEINS E; CALORIC RESTRICTION; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; WEIGHT LOSS;

EID: 34250186089     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.02.003     Document Type: Article

References (25)

1. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
2. Dattilo A.M., and Kris-Etherton P.M. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56 (1992) 320-328
3. Yu-Poth S., Zhao G., Etherton T., Naglak M., Jonnalagadda S., and Kris-Etherton P.M. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69 (1999) 632-646
4. Weber L.W., Boll M., and Stampfl A. Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol 10 (2004) 3081-3087
5. Greenow K., Pearce N.J., and Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J Mol Med 83 (2005) 329-342
6. Meier C.A. Regulation of cholesterol synthesis: of SCAP SREBP, CBP and more. Eur J Endocrinol 136 (1997) 271-272
7. Nakajima T., Hamakubo T., Kodama T., Inazawa J., and Emi M. Genomic structure and chromosomal mapping of the human sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) gene. J Hum Genet 44 (1999) 402-407
8. Brown M.S., and Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340
9. Jia H., Hingorani A.D., Sharma P., et al. Association of the G(s)alpha gene with essential hypertension and response to beta-blockade. Hypertension 34 (1999) 8-14
10. Iwaki K., Nakajima T., Ota N., and Emi M. A common Ile796Val polymorphism of the human SREBP cleavage-activating protein (SCAP) gene. J Hum Genet 44 (1999) 421-422
11. Ilveskoski E., Perola M., Lehtimäki T., et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation 100 (1999) 608-613
12. Rubin J., and Berglund L. Apolipoprotein E and diets: a case of gene-nutrient interaction?. Curr Opin Lipidol 13 (2002) 25-32
13. Fogelholm M., Kukkonen-Harjula K., Nenonen A., and Pasanen M. Effects of walking training on weight maintenance after a very-low-energy diet in premenopausal obese women: a randomized controlled trial. Arch Intern Med 160 (2000) 2177-2184
14. Henderson M., and Freeman C.P. A self-rating scale for bulimia. The "BITE". Br J Psychiatry 150 (1987) 18-24
15. Fogelholm G.M., Sievanen H.T., van Marken Lichtenbelt W.D., and Westerterp K.R. Assessment of fat-mass loss during weight reduction in obese women. Metabolism 46 (1997) 968-975
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
18. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990) 545-548
19. Fan Y.M., Laaksonen R., Janatuinen T., et al. Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. Clin Genet 60 (2001) 319-321
20. Fiegenbaum M., Silveira F.R., Van der S C.R., et al. Determinants of variable response to simvastatin treatment: the role of common variants of SCAP SREBF-1a and SREBF-2 genes. Pharmacogenomics J 5 (2005) 359-364
21. Sarkkinen E., Korhonen M., Erkkila A., Ebeling T., and Uusitupa M. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr 68 (1998) 1215-1222
22. Weggemans R.M., Zock P.L., Ordovas J.M., Pedro-Botet J., and Katan M.B. Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol. Atherosclerosis 154 (2001) 547-555
23. Muls E., Vansant G., Beirinckx A.M., and Jans I. Dietary fat intake in relation to apo E isoforms and body fat distribution in obese women. Acta Cardiol 48 (1993) 473-475
24. Vanhanen M., Kivipelto M., Koivisto K., et al. APOE-epsilon4 is associated with weight loss in women with AD: a population-based study. Neurology 56 (2001) 655-659
25. Kee F., Young I.S., Poirier O., et al. Do polymorphisms of apoB, LPL or apoE affect the hypocholesterolemic response to weight loss?. Atherosclerosis 153 (2000) 119-128